1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with canavanine in 1 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (canavanine) | Trials (canavanine) | Recent Studies (post-2010) (canavanine) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 691 | 0 | 76 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Böhme, E; Schmidt, HH; Seifert, R | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and canavanine
| Article | Year |
|---|---|
Formation and release of nitric oxide from human neutrophils and HL-60 cells induced by a chemotactic peptide, platelet activating factor and leukotriene B4.
Topics: Bucladesine; Calcitriol; Canavanine; Cell Line; Humans; In Vitro Techniques; Kinetics; Leukemia, Promyelocytic, Acute; Leukotriene B4; Luminescence; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Nitric Oxide; Platelet Activating Factor | 1989 |